Research Highlights from ACTRIMS Forum 2023
On February 23-25, 2023, the eighth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum took place in San Diego,…
2022 MS Research Year in Review: Working Together Towards a World Free of MS
Looking back at this past year in research, we reflect on key advances that are accelerating our understanding of multiple sclerosis (MS) and…
Research Highlights from ECTRIMS 2022
On October 26-28, 2022, the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) gathered scientists, clinicians, and…
Meet Five Canadian MS Researchers To Get Excited About
Canadians are known for many things – our hockey teams, maple syrup production, and universal healthcare come to mind – but our MS…
Highlights from ECTRIMS 2021 Digital Congress
On October 13-15, the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) organized a fully digital experience…
2021 Year in Review: The MS Society of Canada is Accelerating Progress in MS Research
Through the generous support of the MS community, event participants, and donors, the Multiple Sclerosis Society of Canada has invested over $204 million…
Multiple Sclerosis and Depression
This blog post was published in October 2021 for #WorldMentalHealthDay to raise awareness of mental health as an integral part of overall health.…
Canadian Researchers Examine the Benefits of Translingual Stimulation (PoNS) Combined with Physiotherapy in Multiple Sclerosis
Drs. Michelle Ploughman (Memorial University of Newfoundland) and Sarah Donkers (University of Saskatchewan) are set to lead the first Canadian clinical trial examining…
Indigenous People and Multiple Sclerosis
Multiple sclerosis (MS) is a disease that does not discriminate – it can affect anyone at any time, often in the prime of their lives. In…
